CN104138630B - 一种呼吸道给药的装置及方法 - Google Patents
一种呼吸道给药的装置及方法 Download PDFInfo
- Publication number
- CN104138630B CN104138630B CN201410369988.9A CN201410369988A CN104138630B CN 104138630 B CN104138630 B CN 104138630B CN 201410369988 A CN201410369988 A CN 201410369988A CN 104138630 B CN104138630 B CN 104138630B
- Authority
- CN
- China
- Prior art keywords
- respiratory tract
- drug
- medicine
- drug particles
- human body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 116
- 238000000034 method Methods 0.000 title abstract description 36
- 238000012377 drug delivery Methods 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 255
- 229940079593 drug Drugs 0.000 claims abstract description 154
- 239000002245 particle Substances 0.000 claims abstract description 127
- 238000000889 atomisation Methods 0.000 claims description 80
- 230000008021 deposition Effects 0.000 claims description 66
- 239000007788 liquid Substances 0.000 claims description 54
- 239000008187 granular material Substances 0.000 claims description 22
- 239000000523 sample Substances 0.000 claims description 18
- 230000005611 electricity Effects 0.000 claims description 14
- 239000000443 aerosol Substances 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 12
- 239000003595 mist Substances 0.000 claims description 12
- 239000006199 nebulizer Substances 0.000 claims description 12
- 235000014347 soups Nutrition 0.000 claims description 9
- 238000004804 winding Methods 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 5
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 5
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 3
- 210000000031 electric organ Anatomy 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 2
- 238000000151 deposition Methods 0.000 abstract description 70
- 230000000694 effects Effects 0.000 abstract description 26
- 230000005684 electric field Effects 0.000 abstract description 18
- 238000010521 absorption reaction Methods 0.000 abstract description 12
- 238000005259 measurement Methods 0.000 abstract description 7
- 238000012544 monitoring process Methods 0.000 abstract description 6
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 238000007599 discharging Methods 0.000 abstract 2
- 238000002347 injection Methods 0.000 description 31
- 239000007924 injection Substances 0.000 description 31
- 239000007921 spray Substances 0.000 description 25
- 238000005507 spraying Methods 0.000 description 25
- 239000000843 powder Substances 0.000 description 19
- 230000002685 pulmonary effect Effects 0.000 description 18
- 210000000214 mouth Anatomy 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 16
- 230000029058 respiratory gaseous exchange Effects 0.000 description 13
- 239000007789 gas Substances 0.000 description 12
- 210000001331 nose Anatomy 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 210000003437 trachea Anatomy 0.000 description 12
- 210000003928 nasal cavity Anatomy 0.000 description 11
- 210000003123 bronchiole Anatomy 0.000 description 10
- 239000004020 conductor Substances 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 10
- 239000004005 microsphere Substances 0.000 description 10
- 238000004062 sedimentation Methods 0.000 description 10
- 238000002604 ultrasonography Methods 0.000 description 10
- 239000002502 liposome Substances 0.000 description 9
- OBRNDARFFFHCGE-QDSVTUBZSA-N arformoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-QDSVTUBZSA-N 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 210000002919 epithelial cell Anatomy 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 210000003800 pharynx Anatomy 0.000 description 6
- 239000000779 smoke Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000000621 bronchi Anatomy 0.000 description 5
- 230000003434 inspiratory effect Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000001133 acceleration Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229960000193 formoterol fumarate Drugs 0.000 description 4
- 210000000867 larynx Anatomy 0.000 description 4
- 229940071648 metered dose inhaler Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000009527 percussion Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010006322 Breath holding Diseases 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 210000000254 ciliated cell Anatomy 0.000 description 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 2
- 229960004316 cisplatin Drugs 0.000 description 2
- 238000000205 computational method Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000004202 respiratory function Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 229940126586 small molecule drug Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- -1 vessel Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000282470 Canis latrans Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 241000883990 Flabellum Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035600 Pleural fibrosis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000010351 charge transfer process Methods 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000003477 cochlea Anatomy 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 210000003685 cricoid cartilage Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000002305 electric material Substances 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000004890 epithelial barrier function Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 206010035653 pneumoconiosis Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410369988.9A CN104138630B (zh) | 2014-07-30 | 2014-07-30 | 一种呼吸道给药的装置及方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410369988.9A CN104138630B (zh) | 2014-07-30 | 2014-07-30 | 一种呼吸道给药的装置及方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104138630A CN104138630A (zh) | 2014-11-12 |
CN104138630B true CN104138630B (zh) | 2017-05-10 |
Family
ID=51848076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410369988.9A Active CN104138630B (zh) | 2014-07-30 | 2014-07-30 | 一种呼吸道给药的装置及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104138630B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3804793A1 (en) * | 2015-10-01 | 2021-04-14 | Mallinckrodt Hospital Products IP Limited | Device for diffusing high concentration no with inhalation therapy gas |
CA3036631A1 (en) * | 2016-12-09 | 2018-06-14 | Trudell Medical International | Smart nebulizer |
EP3338842A1 (en) * | 2016-12-22 | 2018-06-27 | Bernhard Schulz | Nebulizer for laminar flow inhalation of an aerosol |
CN107041985B (zh) * | 2017-04-20 | 2023-06-23 | 成都倍瑞科技有限公司 | 一种手持式人工智能雾化器 |
CN110074308B (zh) * | 2019-04-04 | 2023-04-07 | 肯尼斯.粲.何 | 静电气雾消毒灭菌方法、系统及设备 |
CN111388018B (zh) * | 2020-03-20 | 2023-09-19 | 威图姆卡医疗中心 | 采集下呼吸道样本的方法及其装置、空气消毒方法及其装置 |
CN111420192B (zh) * | 2020-04-09 | 2022-06-21 | 上海新黄河制药有限公司 | 一种原位制备带负电荷粉末的吸入装置 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930061A (en) * | 1974-04-08 | 1975-12-30 | Ransburg Corp | Electrostatic method for forming structures and articles |
US4203398A (en) * | 1976-05-08 | 1980-05-20 | Nissan Motor Company, Limited | Electrostatic apparatus for controlling flow rate of liquid |
CN1053365A (zh) * | 1987-07-18 | 1991-07-31 | 汕头市光电研究所 | 可控间歇性雾化的超声雾化器 |
CN1090208A (zh) * | 1992-12-01 | 1994-08-03 | 电溶胶有限公司 | 给药装置 |
CN101678373A (zh) * | 2007-05-17 | 2010-03-24 | 玛丽皇后与西田学院 | 静电喷射设备和静电喷射方法 |
CN101745182A (zh) * | 2008-12-12 | 2010-06-23 | 三星电子株式会社 | 头脑活动改善机器及皮肤老化防止机器 |
CN102350280A (zh) * | 2011-06-23 | 2012-02-15 | 中国人民解放军第三○九医院 | 具有超声波振动装置的静电液滴发生装置及应用其制备载药凝胶微球的方法 |
CN103736180A (zh) * | 2014-01-13 | 2014-04-23 | 常州正元医疗科技有限公司 | 手持式高频超声雾化全呼吸道药物导入装置 |
-
2014
- 2014-07-30 CN CN201410369988.9A patent/CN104138630B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930061A (en) * | 1974-04-08 | 1975-12-30 | Ransburg Corp | Electrostatic method for forming structures and articles |
US4203398A (en) * | 1976-05-08 | 1980-05-20 | Nissan Motor Company, Limited | Electrostatic apparatus for controlling flow rate of liquid |
CN1053365A (zh) * | 1987-07-18 | 1991-07-31 | 汕头市光电研究所 | 可控间歇性雾化的超声雾化器 |
CN1090208A (zh) * | 1992-12-01 | 1994-08-03 | 电溶胶有限公司 | 给药装置 |
CN101678373A (zh) * | 2007-05-17 | 2010-03-24 | 玛丽皇后与西田学院 | 静电喷射设备和静电喷射方法 |
CN101745182A (zh) * | 2008-12-12 | 2010-06-23 | 三星电子株式会社 | 头脑活动改善机器及皮肤老化防止机器 |
CN102350280A (zh) * | 2011-06-23 | 2012-02-15 | 中国人民解放军第三○九医院 | 具有超声波振动装置的静电液滴发生装置及应用其制备载药凝胶微球的方法 |
CN103736180A (zh) * | 2014-01-13 | 2014-04-23 | 常州正元医疗科技有限公司 | 手持式高频超声雾化全呼吸道药物导入装置 |
Also Published As
Publication number | Publication date |
---|---|
CN104138630A (zh) | 2014-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104138630B (zh) | 一种呼吸道给药的装置及方法 | |
US11247003B2 (en) | Systems and methods of aerosol delivery with airflow regulation | |
US20170368273A1 (en) | Systems and methods of aerosol delivery with airflow regulation | |
Skaria et al. | Omron NE U22: comparison between vibrating mesh and jet nebulizer | |
CN104321103B (zh) | 用于通过雾化给入肺表面活性物质的方法和系统 | |
US8141551B2 (en) | Mouthpiece and flow rate controller for intrapulmonary delivery devices | |
Dessanges | A history of nebulization | |
WO2009005546A1 (en) | High efficiency mouthpiece/adaptor for inhalers | |
JP5746213B2 (ja) | 鼻咽腔、鼻腔、または副鼻腔に対してエアゾールを経口投与するためのデバイス | |
US20120048265A1 (en) | Aerosol drug delivery apparatus and method | |
Longest et al. | Efficient nose-to-lung (N2L) aerosol delivery with a dry powder inhaler | |
CN105722543B (zh) | 通过雾化施用肺表面活性剂的改进的方法和系统 | |
Dugernier et al. | Nasal high-flow nebulization for lung drug delivery: theoretical, experimental, and clinical application | |
Ali | Pulmonary drug delivery | |
Fonceca et al. | Drug administration by inhalation in children | |
CN106823079A (zh) | 一种递送式定量雾化给药装置 | |
Ali et al. | Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral–pharyngeal–laryngeal airways | |
CN204208146U (zh) | 干粉吸入器 | |
WO2014164241A2 (en) | Metered dose atomizer | |
CN207804730U (zh) | 一种递送式定量雾化给药装置 | |
Ehtezazi et al. | Suitability of the upper airway models obtained from MRI studies in simulating drug lung deposition from inhalers | |
CN213252149U (zh) | 一种智能气动自主雾化装置 | |
CN201727813U (zh) | 口鼻两用的超声雾化给药器 | |
Tiddens | Matching the device to the patient | |
Tolman et al. | Aerosol dosage forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Branch of Beijing economic and Technological Development Zone of Beijing City fourteen street 100176 No. 99 building 33 room 508 building B Applicant after: BEIJING YINHEZHIZHOU ENVIRONMENTAL PROTECTION SCIENCE & TECHNOLOGY CO.,LTD. Address before: 100027 Beijing city Chaoyang District Xiaoyun Road No. 32 Concordia Plaza C block 701 Applicant before: BEIJING YINHEZHIZHOU ENVIRONMENTAL PROTECTION SCIENCE & TECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160919 Address after: 215625 Jinxiu Road, Fengzhen, Jiangsu, Zhangjiagang, No. 3 Applicant after: He Zongyan Address before: Branch of Beijing economic and Technological Development Zone of Beijing City fourteen street 100176 No. 99 building 33 room 508 building B Applicant before: BEIJING YINHEZHIZHOU ENVIRONMENTAL PROTECTION SCIENCE & TECHNOLOGY CO.,LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170119 Address after: The 100176 branch of the Beijing economic and Technological Development Zone fourteen Street No. 99 building 33 room 508 building B Applicant after: BEIJING YINHEZHIZHOU ENVIRONMENTAL PROTECTION SCIENCE & TECHNOLOGY CO.,LTD. Address before: 215625 Jinxiu Road, Fengzhen, Jiangsu, Zhangjiagang, No. 3 Applicant before: He Zongyan |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230515 Address after: 1102-495, 11th Floor, Building 3, Yard 20, Guogongzhuang Middle Street, Fengtai District, Beijing, 100070 Patentee after: Nutrition House (Beijing) Technology Development Co.,Ltd. Address before: 100176 room 33, block B, 99 Chuang fourteen street, Beijing economic and Technological Development Zone, 508. Patentee before: BEIJING YINHEZHIZHOU ENVIRONMENTAL PROTECTION SCIENCE & TECHNOLOGY CO.,LTD. |